Avidity Partners Management LP Essa Pharma Inc. Transaction History

Avidity Partners Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.5 - $4.82 $906,900 - $2.91 Million	-604,600 Reduced 24.58%	1,855,400 $4.68 Million
Q4 2021 Feb 14, 2022	BUY	$7.8 - $14.38 $78,000 - $143,800	10,000 Added 0.41%	2,460,000 $34.9 Million
Q3 2021 Nov 15, 2021	SELL	$7.76 - $29.37 $2.33 Million - $8.81 Million	-300,000 Reduced 10.91%	2,450,000 $19.6 Million
Q2 2021 Aug 16, 2021	SELL	$24.17 - $34.28 $2.18 Million - $3.09 Million	-90,000 Reduced 3.17%	2,750,000 $78.6 Million
Q1 2021 May 17, 2021	BUY	$11.61 - $32.08 $3.27 Million - $9.05 Million	282,000 Added 11.02%	2,840,000 $82.5 Million
Q4 2020 Feb 16, 2021	BUY	$5.47 - $12.1 $2.57 Million - $5.69 Million	470,200 Added 22.52%	2,558,000 $30.5 Million
Q3 2020 Nov 16, 2020	BUY	$6.0 - $7.79 $12.5 Million - $16.3 Million	2,087,800 New	2,087,800 $14.4 Million

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $74M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.